Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phacomatosis Pigmentovascularis and Sturge-Weber Syndrome: Comparative Outcomes of Primary Combined Trabeculotomy with Trabeculectomy.

Ophthalmology. Glaucoma·2025
Same author

Outcomes in Primary Congenital Glaucoma, 2011-2023: L V Prasad Eye Institute, Hyderabad.

Ophthalmology. Glaucoma·2025
Same author

Clinical Insights Into a Large Cohort of Phakomatosis Pigmentovascularis.

Journal of glaucoma·2025
Same author

A Survey of the Congenital Glaucoma Surgery Practice Patterns in the Indian Pediatric Glaucoma Society.

Seminars in ophthalmology·2025
Same author

Potential Involvements of Anterior Segment Dysgenesis-Associated Genes in Primary Congenital Glaucoma.

Seminars in ophthalmology·2024
Same author

Potential Involvements of Cilia-Centrosomal Genes in Primary Congenital Glaucoma.

International journal of molecular sciences·2024

Related Experiment Video

Updated: Jun 6, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

dGlucose is linked to renal function changes in diabetes.

Anil K Mandal1, Linda M Hiebert, Harry Khamis

  • 1Department of Medicine, University of Florida, Gainesville, FL, USA. amandal@med-spec.com

Diabetes Research and Clinical Practice
|December 15, 2010
PubMed
Summary
This summary is machine-generated.

The change in glucose (dglucose) from fasting to two hours postprandial better predicts kidney function changes in diabetics than fasting glucose alone. Controlling postprandial hyperglycemia is vital for renal protection.

More Related Videos

Assessment of Kidney Function in Mouse Models of Glomerular Disease
09:16

Assessment of Kidney Function in Mouse Models of Glomerular Disease

Published on: June 30, 2018

Related Experiment Videos

Last Updated: Jun 6, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

Assessment of Kidney Function in Mouse Models of Glomerular Disease
09:16

Assessment of Kidney Function in Mouse Models of Glomerular Disease

Published on: June 30, 2018

Area of Science:

  • Nephrology
  • Endocrinology
  • Diabetology

Background:

  • Diabetes mellitus is a leading cause of chronic kidney disease.
  • Accurate prediction of glycemic control is essential for managing diabetic complications.
  • Fasting glucose and two-hour postprandial glucose are common glycemic markers.

Purpose of the Study:

  • To evaluate if the change in glucose (dglucose) from fasting to two-hour postprandial predicts glycemic control and renal function better than fasting glucose (F) or two-hour postprandial glucose (2 hPPglucose).

Main Methods:

  • Collected fasting glucose, 2-hour postprandial glucose, and renal function variables (BUN, serum creatinine, eGFR) from 56 insulin-treated diabetic adults.
  • Calculated the change in glucose (dglucose = 2 hPPglucose - F).
  • Compared variables between groups with 2 hPPglucose <200 mg/dL and >200 mg/dL, and calculated correlation coefficients.

Main Results:

  • Significant differences were observed between F and 2 hPPglucose for most variables.
  • The change in serum creatinine (dScr) was significant when comparing the two postprandial glucose groups (p=0.0327).
  • dglucose significantly correlated with dScr (r=0.420) and estimated GFR (deGFR) (r=-0.434) in all patients, and particularly in those with 2 hPPglucose >200 mg/dL.

Conclusions:

  • The change in glucose (dglucose) is a superior predictor of renal function changes compared to fasting glucose or 2-hour postprandial glucose alone.
  • Effective control of postprandial hyperglycemia, especially when levels exceed 200 mg/dL, is critical for preserving kidney function in diabetic patients.